|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Savage SA, Mirabello L, Wang Z,
Gastier-Foster JM, Gorlick R, Khanna C, Flanagan AM, Tirabosco R,
Andrulis IL, Wunder JS, et al: Genome-wide association study
identifies two susceptibility loci for osteosarcoma. Nat Genet.
45:799–803. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ohtani Y, Harada T, Funasaka Y, Nakao K,
Takahara C, Abdel-Daim M, Sakai N, Saito N, Nishigori C and Aiba A:
Metabotropic glutamate receptor subtype-1 is essential for in vivo
growth of melanoma. Oncogene. 27:7162–7170. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mathiesen JM, Svendsen N, Bräuner-Osborne
H, Thomsen C and Ramirez MT: Positive allosteric modulation of the
human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and
MPEP. Br J Pharmacol. 138:1026–1030. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Teh J and Chen S: mGlu receptors and
cancerous growth. Wiley Interdiscip Rev Membre Transp Signal.
1:211–220. 2012. View
Article : Google Scholar
|
|
6
|
Ye ZC and Sontheimer H: Glioma cells
release excitotoxic concentrations of glutamate. Cancer Res.
59:4383–4391. 1999.PubMed/NCBI
|
|
7
|
Ryo Y, Miyawaki A, Furuichi T and
Mikoshiba K: Expression of the metabotropic glutamate receptor
mGluR1 alpha and the ionotropic glutamate receptor GluR1 in the
brain during the postnatal development of normal mouse and in the
cerebellum from mutant mice. J Neurosci Res. 36:19–32. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dorsam RT and Gutkind JS:
G-protein-coupled receptors and cancer. Nat Rev Cancer. 7:79–94.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brocke KS, Staufner C, Luksch H, Geiger
KD, Stepulak A, Marzahn J, Schackert G, Temme A and Ikonomidou C:
Glutamate receptors in pediatric tumors of the central nervous
system. Cancer Biol Ther. 9:455–468. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Canudas AM, Di Giorgi-Gerevini V,
Iacovelli L, Nano G, D'Onofrio M, Arcella A, Giangaspero F, Busceti
C, Ricci-Vitiani L, Battaglia G, et al: PHCCC, a specific enhancer
of type 4 metabotropic glutamate receptors, reduces proliferation
and promotes differentiation of cerebellar granule cell
neuroprecursors. J Neurosci. 24:10343–10352. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iacovelli L, Arcella A, Battaglia G,
Pazzaglia S, Aronica E, Spinsanti P, Caruso A, De Smaele E, Saran
A, Gulino A, et al: Pharmacological activation of mGlu4
metabotropic glutamate receptors inhibits the growth of
medulloblastomas. J Neurosci. 26:8388–8397. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Le Poul E, Boléa C, Girard F, Poli S,
Charvin D, Campo B, Bortoli J, Bessif A, Luo B, Koser AJ, et al: A
potent and selective metabotropic glutamate receptor 4 positive
allosteric modulator improves movement in rodent models of
Parkinson's disease. J Pharmacol Exp Ther. 343:167–177. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chang HJ, Yoo BC, Lim SB, Jeong SY, Kim WH
and Park JG: Metabotropic gluamate receptor 4 expression in
colorectal carcinoma and its prognostic significance. Clin Cancer
Res. 11:3288–3295. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang W, Maolin H, Jinmin Z and Zhe W: High
expression of metabotropic glutamate receptor 4: Correlation with
clinicopathologic characteristics and prognosis of osteosarcoma. J
Cancer Res Clin Oncol. 140:419–426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Spencer GL, McGrath CJ and Genever PG:
Current perspectives on NMDA-type glutamate signaling in bone. Int
J Biochem Cell Biol. 39:1089–1104. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stepulak A, Luksch H, Gebhardt C,
Uckermann O, Marzahn J, Sifringer M, Rzeski W, Staufner C, Brocke
KS, Turski L and Ikonomidou C: Expression of glutamate receptor
subunits in human cancers. Histochem Cell Biol. 132:435–445. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takarada-Iemata M, Takarada T, Nakamura Y,
Nakatani E, Hori O and Yoneda Y: Glutamate preferentially
suppresses osteoblastogenesis than adipogenesis through the
cystine/glutamate antiporter in mesenchymal stem cells. J Cell
Physiol. 226:652–665. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Seidlitz EP, Sharma MK and Singh G:
Extracellular glutamate alters mature osteoclast and osteoblast
functions. Can J Physiol Pharmacol. 88:929–936. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Seidlitz EP, Sharma MK, Saikali Z, Ghert M
and Singh G: Cancer cell line release glutamate into the
extracellular environment. Clin Exp Metastasis. 26:781–787. 2009.
View Article : Google Scholar : PubMed/NCBI
|
